ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mesalamine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-27A8791
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Mesalamine Market Outlook 2022
BUY CHAPTERS

Global Mesalamine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-27A8791
Report
June 2025
Pages:159
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Syntese A/S
Divis Laboratories
Ipca Laboratories
Hangzhou Brother
PharmaZell GmbH
Lianyungang Fengheng Biopharm
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Cambrex Corporation
Chemi SPA

Mesalamine Market Size

In 2024, the global market size of Mesalamine was estimated to be worth US$ 186 million and is forecast to reach approximately US$ 239 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.

Mesalamine Market

Mesalamine Market

Mesalamine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.
With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.
Global key players of Mesalamine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalamine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mesalamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalamine.
The Mesalamine market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mesalamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesalamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Mesalamine Market Report

Report Metric Details
Report Name Mesalamine Market
Forecasted market size in 2031 approximately US$ 239 million
CAGR 3.7%
Forecasted years 2025 - 2031
Segment by Type
  • Purity ≥ 97%
  • Purity ≥ 98%
  • Purity ≥ 99%
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Mesalamine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Mesalamine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mesalamine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Mesalamine Market size in 2031?

Ans: The Mesalamine Market size in 2031 will be approximately US$ 239 million.

What is the market share of major companies in Mesalamine Market?

Ans: The top 3 companies hold a share over 50%.

What is the Mesalamine Market share by region?

Ans: Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

Who are the main players in the Mesalamine Market report?

Ans: The main players in the Mesalamine Market are PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical

What are the Application segmentation covered in the Mesalamine Market report?

Ans: The Applications covered in the Mesalamine Market report are Tablets, Capsules, Granule, Suppository, Enema, Others

What are the Type segmentation covered in the Mesalamine Market report?

Ans: The Types covered in the Mesalamine Market report are Purity ≥ 97%, Purity ≥ 98%, Purity ≥ 99%

Recommended Reports

IBD & Colitis Drugs

API & Pharmaceutical Ingredients

GI Treatments & Adjacent

1 Study Coverage
1.1 Mesalamine Product Introduction
1.2 Market by Type
1.2.1 Global Mesalamine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Purity ≥ 97%
1.2.3 Purity ≥ 98%
1.2.4 Purity ≥ 99%
1.3 Market by Application
1.3.1 Global Mesalamine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Granule
1.3.5 Suppository
1.3.6 Enema
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Mesalamine Market Size Estimates and Forecasts
2.1.1 Global Mesalamine Revenue 2020-2031
2.1.2 Global Mesalamine Sales 2020-2031
2.2 Mesalamine Market Size by Region: 2024 Versus 2031
2.3 Mesalamine Sales by Region (2020-2031)
2.3.1 Global Mesalamine Sales by Region: 2020-2025
2.3.2 Global Mesalamine Sales Forecast by Region (2026-2031)
2.3.3 Global Mesalamine Sales Market Share by Region (2020-2031)
2.4 Mesalamine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Mesalamine Revenue by Region: 2020-2025
2.4.2 Global Mesalamine Revenue Forecast by Region (2026-2031)
2.4.3 Global Mesalamine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Mesalamine Sales by Type (2020-2031)
3.1.1.1 Global Mesalamine Sales Volume by Type (2020-2031)
3.1.1.2 Global Mesalamine Sales Market Share by Type (2020-2031)
3.1.2 Global Mesalamine Revenue by Type (2020-2031)
3.1.2.1 Global Mesalamine Revenue by Type (2020-2031)
3.1.2.2 Global Mesalamine Revenue Market Share by Type (2020-2031)
3.1.3 Mesalamine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Mesalamine Sales by Application (2020-2031)
3.2.1.1 Global Mesalamine Sales Volume by Application (2020-2031)
3.2.1.2 Global Mesalamine Sales Market Share by Application (2020-2031)
3.2.2 Global Mesalamine Revenue by Application (2020-2031)
3.2.2.1 Global Mesalamine Revenue by Application (2020-2031)
3.2.2.2 Global Mesalamine Revenue Market Share by Application (2020-2031)
3.2.3 Mesalamine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Purity ≥ 97% of Mesalamine Revenue Market Share by Application
3.3.2 Purity ≥ 98% of Mesalamine Revenue Market Share by Application
3.3.3 Purity ≥ 99% of Mesalamine Revenue Market Share by Application
4 Global Mesalamine by Manufacturers
4.1 Global Top Mesalamine Manufacturers by Sales (2020-2025)
4.1.1 Global Mesalamine Sales by Manufacturer (2020-2025)
4.1.2 Global Mesalamine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Mesalamine Manufacturers by Revenue (2020-2025)
4.2.1 Global Mesalamine Revenue by Manufacturer (2020-2025)
4.2.2 Global Mesalamine Revenue Share by Manufacturer (2020-2025)
4.3 Global Mesalamine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Mesalamine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Mesalamine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Mesalamine Manufacturing Base Distribution, Product Type
4.5.1 Mesalamine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Mesalamine Market
4.5.3 Manufacturers Mesalamine Product Type and Application
4.5.4 Purity ≥ 97% Market Sales of Mesalamine by Manufacturer
4.5.5 Purity ≥ 98% Market Sales of Mesalamine by Manufacturer
4.5.6 Purity ≥ 99% Market Sales of Mesalamine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 PharmaZell
5.1.1 PharmaZell Company Information
5.1.2 PharmaZell Description, Business Overview
5.1.3 PharmaZell Mesalamine Products Offered
5.1.4 PharmaZell Mesalamine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 PharmaZell Mesalamine Sales by Product in 2024
5.1.6 PharmaZell Mesalamine Sales by Application in 2024
5.1.7 PharmaZell Mesalamine Sales by Geographic Area in 2024
5.1.8 PharmaZell Recent Developments
5.2 Syntese A/S
5.2.1 Syntese A/S Company Information
5.2.2 Syntese A/S Description, Business Overview
5.2.3 Syntese A/S Mesalamine Products Offered
5.2.4 Syntese A/S Mesalamine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Syntese A/S Mesalamine Sales by Product in 2024
5.2.6 Syntese A/S Mesalamine Sales by Application in 2024
5.2.7 Syntese A/S Mesalamine Sales by Geographic Area in 2024
5.2.8 Syntese A/S Recent Developments
5.3 Cambrex Corporation
5.3.1 Cambrex Corporation Company Information
5.3.2 Cambrex Corporation Description, Business Overview
5.3.3 Cambrex Corporation Mesalamine Products Offered
5.3.4 Cambrex Corporation Mesalamine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Cambrex Corporation Mesalamine Sales by Product in 2024
5.3.6 Cambrex Corporation Mesalamine Sales by Application in 2024
5.3.7 Cambrex Corporation Mesalamine Sales by Geographic Area in 2024
5.3.8 Cambrex Corporation Recent Developments
5.4 Divis Laboratories
5.4.1 Divis Laboratories Company Information
5.4.2 Divis Laboratories Description, Business Overview
5.4.3 Divis Laboratories Mesalamine Products Offered
5.4.4 Divis Laboratories Mesalamine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Divis Laboratories Mesalamine Sales by Product in 2024
5.4.6 Divis Laboratories Mesalamine Sales by Application in 2024
5.4.7 Divis Laboratories Mesalamine Sales by Geographic Area in 2024
5.4.8 Divis Laboratories Recent Developments
5.5 Chemi SpA
5.5.1 Chemi SpA Company Information
5.5.2 Chemi SpA Description, Business Overview
5.5.3 Chemi SpA Mesalamine Products Offered
5.5.4 Chemi SpA Mesalamine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Chemi SpA Mesalamine Sales by Product in 2024
5.5.6 Chemi SpA Mesalamine Sales by Application in 2024
5.5.7 Chemi SpA Mesalamine Sales by Geographic Area in 2024
5.5.8 Chemi SpA Recent Developments
5.6 Ipca Laboratories
5.6.1 Ipca Laboratories Company Information
5.6.2 Ipca Laboratories Description, Business Overview
5.6.3 Ipca Laboratories Mesalamine Products Offered
5.6.4 Ipca Laboratories Mesalamine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Ipca Laboratories Mesalamine Sales by Product in 2024
5.6.6 Ipca Laboratories Mesalamine Sales by Application in 2024
5.6.7 Ipca Laboratories Mesalamine Sales by Geographic Area in 2024
5.6.8 Ipca Laboratories Recent Developments
5.7 Hangzhou Brother
5.7.1 Hangzhou Brother Company Information
5.7.2 Hangzhou Brother Description, Business Overview
5.7.3 Hangzhou Brother Mesalamine Products Offered
5.7.4 Hangzhou Brother Mesalamine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Hangzhou Brother Mesalamine Sales by Product in 2024
5.7.6 Hangzhou Brother Mesalamine Sales by Application in 2024
5.7.7 Hangzhou Brother Mesalamine Sales by Geographic Area in 2024
5.7.8 Hangzhou Brother Recent Developments
5.8 Lianyungang Fengheng Biopharm
5.8.1 Lianyungang Fengheng Biopharm Company Information
5.8.2 Lianyungang Fengheng Biopharm Description, Business Overview
5.8.3 Lianyungang Fengheng Biopharm Mesalamine Products Offered
5.8.4 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Lianyungang Fengheng Biopharm Mesalamine Sales by Product in 2024
5.8.6 Lianyungang Fengheng Biopharm Mesalamine Sales by Application in 2024
5.8.7 Lianyungang Fengheng Biopharm Mesalamine Sales by Geographic Area in 2024
5.8.8 Lianyungang Fengheng Biopharm Recent Developments
5.9 Lasa Loboratory
5.9.1 Lasa Loboratory Company Information
5.9.2 Lasa Loboratory Description, Business Overview
5.9.3 Lasa Loboratory Mesalamine Products Offered
5.9.4 Lasa Loboratory Mesalamine Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Lasa Loboratory Mesalamine Sales by Product in 2024
5.9.6 Lasa Loboratory Mesalamine Sales by Application in 2024
5.9.7 Lasa Loboratory Mesalamine Sales by Geographic Area in 2024
5.9.8 Lasa Loboratory Recent Developments
5.10 Corden Pharma Bergamo
5.10.1 Corden Pharma Bergamo Company Information
5.10.2 Corden Pharma Bergamo Description, Business Overview
5.10.3 Corden Pharma Bergamo Mesalamine Products Offered
5.10.4 Corden Pharma Bergamo Mesalamine Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Corden Pharma Bergamo Mesalamine Sales by Product in 2024
5.10.6 Corden Pharma Bergamo Mesalamine Sales by Application in 2024
5.10.7 Corden Pharma Bergamo Mesalamine Sales by Geographic Area in 2024
5.10.8 Corden Pharma Bergamo Recent Developments
5.11 Erregierre SpA
5.11.1 Erregierre SpA Company Information
5.11.2 Erregierre SpA Description, Business Overview
5.11.3 Erregierre SpA Mesalamine Products Offered
5.11.4 Erregierre SpA Mesalamine Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Erregierre SpA Mesalamine Sales by Product in 2024
5.11.6 Erregierre SpA Mesalamine Sales by Application in 2024
5.11.7 Erregierre SpA Mesalamine Sales by Geographic Area in 2024
5.11.8 Erregierre SpA Recent Developments
5.12 CTX Lifescience
5.12.1 CTX Lifescience Company Information
5.12.2 CTX Lifescience Description, Business Overview
5.12.3 CTX Lifescience Mesalamine Products Offered
5.12.4 CTX Lifescience Mesalamine Sales, Revenue and Gross Margin (2020-2025)
5.12.5 CTX Lifescience Mesalamine Sales by Product in 2024
5.12.6 CTX Lifescience Mesalamine Sales by Application in 2024
5.12.7 CTX Lifescience Mesalamine Sales by Geographic Area in 2024
5.12.8 CTX Lifescience Recent Developments
5.13 Ishita Active Pharma Ingredients
5.13.1 Ishita Active Pharma Ingredients Company Information
5.13.2 Ishita Active Pharma Ingredients Description, Business Overview
5.13.3 Ishita Active Pharma Ingredients Mesalamine Products Offered
5.13.4 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Ishita Active Pharma Ingredients Mesalamine Sales by Product in 2024
5.13.6 Ishita Active Pharma Ingredients Mesalamine Sales by Application in 2024
5.13.7 Ishita Active Pharma Ingredients Mesalamine Sales by Geographic Area in 2024
5.13.8 Ishita Active Pharma Ingredients Recent Developments
5.14 YC Biotech (Jiangsu)
5.14.1 YC Biotech (Jiangsu) Company Information
5.14.2 YC Biotech (Jiangsu) Description, Business Overview
5.14.3 YC Biotech (Jiangsu) Mesalamine Products Offered
5.14.4 YC Biotech (Jiangsu) Mesalamine Sales, Revenue and Gross Margin (2020-2025)
5.14.5 YC Biotech (Jiangsu) Mesalamine Sales by Product in 2024
5.14.6 YC Biotech (Jiangsu) Mesalamine Sales by Application in 2024
5.14.7 YC Biotech (Jiangsu) Mesalamine Sales by Geographic Area in 2024
5.14.8 YC Biotech (Jiangsu) Recent Developments
5.15 Xinxiang Tianfeng Fine Chemical
5.15.1 Xinxiang Tianfeng Fine Chemical Company Information
5.15.2 Xinxiang Tianfeng Fine Chemical Description, Business Overview
5.15.3 Xinxiang Tianfeng Fine Chemical Mesalamine Products Offered
5.15.4 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue and Gross Margin (2020-2025)
5.15.5 Xinxiang Tianfeng Fine Chemical Mesalamine Sales by Product in 2024
5.15.6 Xinxiang Tianfeng Fine Chemical Mesalamine Sales by Application in 2024
5.15.7 Xinxiang Tianfeng Fine Chemical Mesalamine Sales by Geographic Area in 2024
5.15.8 Xinxiang Tianfeng Fine Chemical Recent Developments
6 North America
6.1 North America Mesalamine Market Size YoY Growth 2020-2031
6.2 North America Mesalamine Market Facts & Figures by Country
6.2.1 North America Mesalamine Sales by Country (2020-2031)
6.2.2 North America Mesalamine Revenue by Country (2020-2031)
6.3 North America Mesalamine Sales by Type (2020-2025)
6.4 North America Mesalamine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Mesalamine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Mesalamine Market Facts & Figures by Region
7.2.1 Asia-Pacific Mesalamine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Mesalamine Revenue by Region (2020-2031)
7.3 Asia-Pacific Mesalamine Sales by Type (2020-2025)
7.4 Asia-Pacific Mesalamine Sales by Application (2020-2025)
8 Europe
8.1 Europe Mesalamine Market Size YoY Growth 2020-2031
8.2 Europe Mesalamine Market Facts & Figures by Country
8.2.1 Europe Mesalamine Sales by Country (2020-2031)
8.2.2 Europe Mesalamine Revenue by Country (2020-2031)
8.3 Europe Mesalamine Sales by Type (2020-2025)
8.4 Europe Mesalamine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Mesalamine Market Size YoY Growth 2020-2031
9.2 Latin America Mesalamine Market Facts & Figures by Country
9.2.1 Latin America Mesalamine Sales by Country (2020-2031)
9.2.2 Latin America Mesalamine Revenue by Country (2020-2031)
9.3 Latin America Mesalamine Sales by Type (2020-2025)
9.4 Latin America Mesalamine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Mesalamine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Mesalamine Market Facts & Figures by Country
10.2.1 Middle East and Africa Mesalamine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Mesalamine Revenue by Country (2020-2031)
10.3 Middle East and Africa Mesalamine Sales by Type (2020-2025)
10.4 Middle East and Africa Mesalamine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Mesalamine Supply Chain Analysis
11.2 Mesalamine Key Raw Materials and Upstream Suppliers
11.3 Mesalamine Clients Analysis
11.4 Mesalamine Sales Channel and Sales Model Analysis
11.4.1 Mesalamine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Mesalamine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Mesalamine Distributors
12 Mesalamine Market Dynamics
12.1 Mesalamine Industry Trends
12.2 Mesalamine Market Drivers
12.3 Mesalamine Market Challenges
12.4 Mesalamine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Syntese A/S
Divis Laboratories
Ipca Laboratories
Hangzhou Brother
PharmaZell GmbH
Lianyungang Fengheng Biopharm
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Cambrex Corporation
Chemi SPA
List of Tables
 Table 1. Global Mesalamine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Mesalamine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Mesalamine Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Mesalamine Sales by Region (2020-2025) & (Tons)
 Table 5. Global Mesalamine Sales Forecast by Region (2026-2031) & (Tons)
 Table 6. Global Mesalamine Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Mesalamine Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Mesalamine Sales Volume by Type (2020-2025) & (Tons)
 Table 9. Global Mesalamine Sales Volume by Type (2026-2031) & (Tons)
 Table 10. Global Mesalamine Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Mesalamine Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Mesalamine Sales Volume by Application (2020-2025) & (Tons)
 Table 13. Global Mesalamine Sales Volume by Application (2026-2031) & (Tons)
 Table 14. Global Mesalamine Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Mesalamine Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Mesalamine Sales by Manufacturer (2020-2025) & (Tons)
 Table 17. Global Mesalamine Sales Share by Manufacturer (2020-2025)
 Table 18. Mesalamine Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Mesalamine Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Mesalamine Price (2020-2025) & (US$/kg)
 Table 21. Ranking of Global Top Mesalamine Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Mesalamine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Mesalamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalamine as of 2024)
 Table 24. Mesalamine Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Mesalamine Market
 Table 26. Manufacturers Mesalamine Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. PharmaZell Company Information
 Table 29. PharmaZell Description and Business Overview
 Table 30. PharmaZell Mesalamine Product
 Table 31. PharmaZell Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 32. PharmaZell Sales Proportion of Mesalamine by Product in 2024
 Table 33. PharmaZell Sales Proportion of Mesalamine by Application in 2024
 Table 34. PharmaZell Sales Proportion of Mesalamine by Geographic Area in 2024
 Table 35. PharmaZell Recent Developments
 Table 36. Syntese A/S Company Information
 Table 37. Syntese A/S Description and Business Overview
 Table 38. Syntese A/S Mesalamine Product
 Table 39. Syntese A/S Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 40. Syntese A/S Sales Proportion of Mesalamine by Product in 2024
 Table 41. Syntese A/S Sales Proportion of Mesalamine by Application in 2024
 Table 42. Syntese A/S Sales Proportion of Mesalamine by Geographic Area in 2024
 Table 43. Syntese A/S Recent Developments
 Table 44. Cambrex Corporation Company Information
 Table 45. Cambrex Corporation Description and Business Overview
 Table 46. Cambrex Corporation Mesalamine Product
 Table 47. Cambrex Corporation Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 48. Cambrex Corporation Sales Proportion of Mesalamine by Product in 2024
 Table 49. Cambrex Corporation Sales Proportion of Mesalamine by Application in 2024
 Table 50. Cambrex Corporation Sales Proportion of Mesalamine by Geographic Area in 2024
 Table 51. Cambrex Corporation Recent Developments
 Table 52. Divis Laboratories Company Information
 Table 53. Divis Laboratories Description and Business Overview
 Table 54. Divis Laboratories Mesalamine Product
 Table 55. Divis Laboratories Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 56. Divis Laboratories Sales Proportion of Mesalamine by Product in 2024
 Table 57. Divis Laboratories Sales Proportion of Mesalamine by Application in 2024
 Table 58. Divis Laboratories Sales Proportion of Mesalamine by Geographic Area in 2024
 Table 59. Divis Laboratories Recent Developments
 Table 60. Chemi SpA Company Information
 Table 61. Chemi SpA Description and Business Overview
 Table 62. Chemi SpA Mesalamine Product
 Table 63. Chemi SpA Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 64. Chemi SpA Sales Proportion of Mesalamine by Product in 2024
 Table 65. Chemi SpA Sales Proportion of Mesalamine by Application in 2024
 Table 66. Chemi SpA Sales Proportion of Mesalamine by Geographic Area in 2024
 Table 67. Chemi SpA Recent Developments
 Table 68. Ipca Laboratories Company Information
 Table 69. Ipca Laboratories Description and Business Overview
 Table 70. Ipca Laboratories Mesalamine Product
 Table 71. Ipca Laboratories Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 72. Ipca Laboratories Sales Proportion of Mesalamine by Product in 2024
 Table 73. Ipca Laboratories Sales Proportion of Mesalamine by Application in 2024
 Table 74. Ipca Laboratories Sales Proportion of Mesalamine by Geographic Area in 2024
 Table 75. Ipca Laboratories Recent Developments
 Table 76. Hangzhou Brother Company Information
 Table 77. Hangzhou Brother Description and Business Overview
 Table 78. Hangzhou Brother Mesalamine Product
 Table 79. Hangzhou Brother Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 80. Hangzhou Brother Sales Proportion of Mesalamine by Product in 2024
 Table 81. Hangzhou Brother Sales Proportion of Mesalamine by Application in 2024
 Table 82. Hangzhou Brother Sales Proportion of Mesalamine by Geographic Area in 2024
 Table 83. Hangzhou Brother Recent Developments
 Table 84. Lianyungang Fengheng Biopharm Company Information
 Table 85. Lianyungang Fengheng Biopharm Description and Business Overview
 Table 86. Lianyungang Fengheng Biopharm Mesalamine Product
 Table 87. Lianyungang Fengheng Biopharm Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 88. Lianyungang Fengheng Biopharm Sales Proportion of Mesalamine by Product in 2024
 Table 89. Lianyungang Fengheng Biopharm Sales Proportion of Mesalamine by Application in 2024
 Table 90. Lianyungang Fengheng Biopharm Sales Proportion of Mesalamine by Geographic Area in 2024
 Table 91. Lianyungang Fengheng Biopharm Recent Developments
 Table 92. Lasa Loboratory Company Information
 Table 93. Lasa Loboratory Description and Business Overview
 Table 94. Lasa Loboratory Mesalamine Product
 Table 95. Lasa Loboratory Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 96. Lasa Loboratory Sales Proportion of Mesalamine by Product in 2024
 Table 97. Lasa Loboratory Sales Proportion of Mesalamine by Application in 2024
 Table 98. Lasa Loboratory Sales Proportion of Mesalamine by Geographic Area in 2024
 Table 99. Lasa Loboratory Recent Developments
 Table 100. Corden Pharma Bergamo Company Information
 Table 101. Corden Pharma Bergamo Description and Business Overview
 Table 102. Corden Pharma Bergamo Mesalamine Product
 Table 103. Corden Pharma Bergamo Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 104. Corden Pharma Bergamo Sales Proportion of Mesalamine by Product in 2024
 Table 105. Corden Pharma Bergamo Sales Proportion of Mesalamine by Application in 2024
 Table 106. Corden Pharma Bergamo Sales Proportion of Mesalamine by Geographic Area in 2024
 Table 107. Corden Pharma Bergamo Recent Developments
 Table 108. Erregierre SpA Company Information
 Table 109. Erregierre SpA Description and Business Overview
 Table 110. Erregierre SpA Mesalamine Product
 Table 111. Erregierre SpA Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 112. Erregierre SpA Sales Proportion of Mesalamine by Product in 2024
 Table 113. Erregierre SpA Sales Proportion of Mesalamine by Application in 2024
 Table 114. Erregierre SpA Sales Proportion of Mesalamine by Geographic Area in 2024
 Table 115. Erregierre SpA Recent Developments
 Table 116. CTX Lifescience Company Information
 Table 117. CTX Lifescience Description and Business Overview
 Table 118. CTX Lifescience Mesalamine Product
 Table 119. CTX Lifescience Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 120. CTX Lifescience Sales Proportion of Mesalamine by Product in 2024
 Table 121. CTX Lifescience Sales Proportion of Mesalamine by Application in 2024
 Table 122. CTX Lifescience Sales Proportion of Mesalamine by Geographic Area in 2024
 Table 123. CTX Lifescience Recent Developments
 Table 124. Ishita Active Pharma Ingredients Company Information
 Table 125. Ishita Active Pharma Ingredients Description and Business Overview
 Table 126. Ishita Active Pharma Ingredients Mesalamine Product
 Table 127. Ishita Active Pharma Ingredients Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 128. Ishita Active Pharma Ingredients Sales Proportion of Mesalamine by Product in 2024
 Table 129. Ishita Active Pharma Ingredients Sales Proportion of Mesalamine by Application in 2024
 Table 130. Ishita Active Pharma Ingredients Sales Proportion of Mesalamine by Geographic Area in 2024
 Table 131. Ishita Active Pharma Ingredients Recent Developments
 Table 132. YC Biotech (Jiangsu) Company Information
 Table 133. YC Biotech (Jiangsu) Description and Business Overview
 Table 134. YC Biotech (Jiangsu) Mesalamine Product
 Table 135. YC Biotech (Jiangsu) Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 136. YC Biotech (Jiangsu) Sales Proportion of Mesalamine by Product in 2024
 Table 137. YC Biotech (Jiangsu) Sales Proportion of Mesalamine by Application in 2024
 Table 138. YC Biotech (Jiangsu) Sales Proportion of Mesalamine by Geographic Area in 2024
 Table 139. YC Biotech (Jiangsu) Recent Developments
 Table 140. Xinxiang Tianfeng Fine Chemical Company Information
 Table 141. Xinxiang Tianfeng Fine Chemical Description and Business Overview
 Table 142. Xinxiang Tianfeng Fine Chemical Mesalamine Product
 Table 143. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 144. Xinxiang Tianfeng Fine Chemical Sales Proportion of Mesalamine by Product in 2024
 Table 145. Xinxiang Tianfeng Fine Chemical Sales Proportion of Mesalamine by Application in 2024
 Table 146. Xinxiang Tianfeng Fine Chemical Sales Proportion of Mesalamine by Geographic Area in 2024
 Table 147. Xinxiang Tianfeng Fine Chemical Recent Developments
 Table 148. North America Mesalamine Sales by Country (2020-2025) & (Tons)
 Table 149. North America Mesalamine Sales by Country (2026-2031) & (Tons)
 Table 150. North America Mesalamine Revenue by Country (2020-2025) & (US$ Million)
 Table 151. North America Mesalamine Revenue by Country (2026-2031) & (US$ Million)
 Table 152. North America Mesalamine Sales by Type (2020-2025) & (Tons)
 Table 153. North America Mesalamine Sales by Application (2020-2025) & (Tons)
 Table 154. Asia-Pacific Mesalamine Sales by Region (2020-2025) & (Tons)
 Table 155. Asia-Pacific Mesalamine Sales by Region (2026-2031) & (Tons)
 Table 156. Asia-Pacific Mesalamine Revenue by Region (2020-2025) & (US$ Million)
 Table 157. Asia-Pacific Mesalamine Revenue by Region (2026-2031) & (US$ Million)
 Table 158. Asia-Pacific Mesalamine Sales by Type (2020-2025) & (Tons)
 Table 159. Asia-Pacific Mesalamine Sales by Application (2020-2025) & (Tons)
 Table 160. Europe Mesalamine Sales by Country (2020-2025) & (Tons)
 Table 161. Europe Mesalamine Sales by Country (2026-2031) & (Tons)
 Table 162. Europe Mesalamine Revenue by Country (2020-2025) & (US$ Million)
 Table 163. Europe Mesalamine Revenue by Country (2026-2031) & (US$ Million)
 Table 164. Europe Mesalamine Sales by Type (2020-2025) & (Tons)
 Table 165. Europe Mesalamine Sales by Application (2020-2025) & (Tons)
 Table 166. Latin America Mesalamine Sales by Country (2020-2025) & (Tons)
 Table 167. Latin America Mesalamine Sales by Country (2026-2031) & (Tons)
 Table 168. Latin America Mesalamine Revenue by Country (2020-2025) & (US$ Million)
 Table 169. Latin America Mesalamine Revenue by Country (2026-2031) & (US$ Million)
 Table 170. Latin America Mesalamine Sales by Type (2020-2025) & (Tons)
 Table 171. Latin America Mesalamine Sales by Application (2020-2025) & (Tons)
 Table 172. Middle East and Africa Mesalamine Sales by Country (2020-2025) & (Tons)
 Table 173. Middle East and Africa Mesalamine Sales by Country (2026-2031) & (Tons)
 Table 174. Middle East and Africa Mesalamine Revenue by Country (2020-2025) & (US$ Million)
 Table 175. Middle East and Africa Mesalamine Revenue by Country (2026-2031) & (US$ Million)
 Table 176. Middle East and Africa Mesalamine Sales by Type (2020-2025) & (Tons)
 Table 177. Middle East and Africa Mesalamine Sales by Application (2020-2025) & (Tons)
 Table 178. Mesalamine Key Raw Materials, Industry Status and Trend
 Table 179. Mesalamine Key Raw Materials and Upstream Suppliers
 Table 180. Mesalamine Clients Status and Trend
 Table 181. Mesalamine Typical Clients
 Table 182. Mesalamine Distributors
 Table 183. Mesalamine Market Trends
 Table 184. Mesalamine Market Drivers
 Table 185. Mesalamine Market Challenges
 Table 186. Mesalamine Market Restraints
 Table 187. Research Programs/Design for This Report
 Table 188. Key Data Information from Secondary Sources
 Table 189. Key Data Information from Primary Sources
 Table 190. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Mesalamine Product Picture
 Figure 2. Global Mesalamine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Mesalamine Sales Market Share by Type in 2024 & 2031
 Figure 4. Purity ≥ 97% Product Picture
 Figure 5. Purity ≥ 98% Product Picture
 Figure 6. Purity ≥ 99% Product Picture
 Figure 7. Global Mesalamine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Mesalamine Sales Market Share by Application in 2024 & 2031
 Figure 9. Tablets
 Figure 10. Capsules
 Figure 11. Granule
 Figure 12. Suppository
 Figure 13. Enema
 Figure 14. Others
 Figure 15. Mesalamine Report Years Considered
 Figure 16. Global Mesalamine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Mesalamine Market Size 2020-2031 (US$ Million)
 Figure 18. Global Mesalamine Sales 2020-2031 (Tons)
 Figure 19. Global Mesalamine Sales Market Share Forecast by Region (2020-2031)
 Figure 20. Global Mesalamine Revenue Market Share by Region (2020-2031)
 Figure 21. Global Mesalamine Sales Market Share Forecast by Type (2020-2031)
 Figure 22. Global Mesalamine Revenue Market Share Forecast by Type (2020-2031)
 Figure 23. Mesalamine Average Selling Price (ASP) by Type (2020-2025) & (US$/kg)
 Figure 24. Global Mesalamine Sales Market Share Forecast by Application (2020-2031)
 Figure 25. Global Mesalamine Revenue Market Share Forecast by Application (2020-2031)
 Figure 26. Mesalamine Average Selling Price (ASP) by Application (2020-2025) & (US$/kg)
 Figure 27. Purity ≥ 97% of Mesalamine Revenue Market Share by Application, 2024 VS 2031
 Figure 28. Purity ≥ 98% of Mesalamine Revenue Market Share by Application, 2024 VS 2031
 Figure 29. Purity ≥ 99% of Mesalamine Revenue Market Share by Application, 2024 VS 2031
 Figure 30. Global Mesalamine Sales Share by Manufacturer in 2024
 Figure 31. Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 32. Purity ≥ 97% Market Sales Proportion by Manufacturer in 2024
 Figure 33. Purity ≥ 98% Market Sales Proportion by Manufacturer in 2024
 Figure 34. Purity ≥ 99% Market Sales Proportion by Manufacturer in 2024
 Figure 35. North America Mesalamine Revenue 2020-2031 (US$ Million)
 Figure 36. North America Mesalamine Sales Market Share by Type (2020-2025)
 Figure 37. North America Mesalamine Sales Market Share by Application (2020-2025)
 Figure 38. Asia-Pacific Mesalamine Revenue 2020-2031 (US$ Million)
 Figure 39. Asia-Pacific Mesalamine Sales Market Share by Region (2020-2031)
 Figure 40. Asia-Pacific Mesalamine Revenue Market Share by Region (2020-2031)
 Figure 41. Asia-Pacific Mesalamine Sales Market Share by Type (2020-2025)
 Figure 42. Asia-Pacific Mesalamine Sales Market Share by Application (2020-2025)
 Figure 43. Europe Mesalamine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 44. Europe Mesalamine Sales Market Share by Country (2020-2031)
 Figure 45. Europe Mesalamine Revenue Market Share by Country (2020-2031)
 Figure 46. Europe Mesalamine Sales Market Share by Type (2020-2025)
 Figure 47. Europe Mesalamine Sales Market Share by Application (2020-2025)
 Figure 48. Latin America Mesalamine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 49. Latin America Mesalamine Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Mesalamine Revenue Market Share by Country (2020-2025)
 Figure 51. Latin America Mesalamine Sales Market Share by Type (2020-2025)
 Figure 52. Latin America Mesalamine Sales Market Share by Application (2020-2025)
 Figure 53. Middle East and Africa Mesalamine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 54. Middle East and Africa Mesalamine Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Mesalamine Revenue Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Mesalamine Sales Market Share by Type (2020-2025)
 Figure 57. Middle East and Africa Mesalamine Sales Market Share by Application (2020-2025)
 Figure 58. Mesalamine Supply Chain (Upstream and Downstream Market)
 Figure 59. Global Production Market Share of Mesalamine Raw Materials by Region in 2024
 Figure 60. Mesalamine Distribution Channels
 Figure 61. Global Mesalamine Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 62. Global Mesalamine Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Mesalazine Market Research Report 2024
Global Mesalazine API Market Research Report 2025
Oral Mesalazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mesalamine API Market Research Report 2024
Rectal Mesalazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
5 aminosalicylic Acid API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mesalazine Suppositories Market Research Report 2024
Mesalamine Lialda Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug for Ulcerative Colitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ulcerative Colitis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ulcerative Colitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Balsalazide Disodium Market Research Report 2025
Global Aminosalicylic Acid Preparation Market Insights Forecast to 2030
Global Adalimumab Market Insights Forecast to 2030
Global Sodium 4 Aminosalicylate Market Research Report 2024
Global Small Molecules Drugs for Inflammatory Bowel Diseases IBDs Market Research Report 2024
Global Humira Market Insights Forecast to 2030
Global Salicylsalicylic Acid Market Research Report 2024
Global Aminosalicylate Sodium Market Research Report 2025
Global Sulfapyridine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions